Nonalcoholic fatty liver disease (NAFLD) is an increasingly recognized cause of liver-related
morbidity and mortality. It can develop secondary to numerous causes but a great majority of …

The success of highly active antiretroviral therapy (HAART) has determined a dramatic
decline in AIDS-and immunodeficiency-related causes of death in the HIV-infected …

Background Cardio-metabolic risk factors are of increasing concern in HIV-infected
individuals, particularly with the advent of antiretroviral therapy (ART) and the subsequent …

Fortified blended foods (FBF), especially corn soy blend, are used as food aid for millions of
people worldwide, especially malnourished individuals and vulnerable groups. There are …

Metabolic complications associated with HIV infection and treatment frequently present as a
relative lack of peripheral adipose tissue associated with dyslipidemia and insulin …

Background. The metabolic syndrome is a clustering of hyperglycemia/insulin resistance,
hypertension, dyslipidemia, and obesity which are risk factors for cardiovascular disease …

People with HIV infection have metabolic abnormalities that resemble metabolic syndrome
(hypertriglyceridemia, low high-density lipoprotein cholesterol, and insulin resistance) …

Antiretroviral therapy has revolutionized the care of people with human immunodeficiency
virus (HIV) by reducing morbidity and mortality from acquired immunodeficiency syndrome …

Background HIV infection and highly active antiretroviral therapy (HAART) can induce
metabolic disturbances including lipodystrophy, dyslipidemia, and insulin resistance, which …

HIV-infected patients on highly active antiretroviral therapy (HAART) have increased
prevalence of a number of chronic metabolic disorders of multifactorial but unclear etiology …